Q
PFE icon

QVR’s Pfizer PFE Stock Holding History

QVR’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,400
Closed -$430K – 134
2022
Q4 		$430K Sell
8,400
-77,100
-90% -$3.7M 0.05% 54
2022
Q3 		$3.74M Buy
85,500
+31,100
+57% +$1.51M 0.31% 51
2022
Q2 		$2.85M Sell
54,400
-110,400
-67% -$5.63M 0.21% 65
2022
Q1 		$8.53M Buy
164,800
+164,200
+27,367% +$8.52M 0.33% 56
2021
Q4 		$35K Sell
600
-73,500
-99% -$3.64M 0.01% 13
2021
Q3 		$3.19M Buy
74,100
+47,400
+178% +$2.1M 0.21% 58
2021
Q2 		$1.05M Buy
26,700
+20,700
+345% +$805K 0.11% 102
2021
Q1 		$217K Sell
6,000
-1,900
-24% -$67.5K 0.02% 124
2020
Q4 		$291K Buy
+7,900
New +$290K 0.03% 41

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QVR's PFE Position: Q2 2026 in Review

QVR sold out of Pfizer (PFE) in Q2 2026, closing a stake of 11,622 shares — an estimated $326K sold.

QVR first reported a position in PFE in Q1 2021 and held it in 8 quarters. The position peaked at $1.25M in Q3 2022. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • QVR reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • QVR sold 11,622 Pfizer shares in Q2 2026, an estimated $326K.
  • QVR first reported a position in Pfizer in Q1 2021 and held it in 8 quarters.
  • QVR's Pfizer position peaked at $1.25M in Q3 2022.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.